Apolipoprotein A2 and C3 Polypeptides for Inflammation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments are inadequate for effectively reducing or preventing chronic and acute inflammatory responses, particularly in autoimmune diseases and injuries, where chronic inflammation poses a significant health burden affecting millions of people.
Innovation Solution
Administration of polypeptides containing Apolipoprotein A2 and Apolipoprotein C3 amino acid sequences, either alone or in combination, to regulate and inhibit inflammatory responses by reducing cytokine expression and activity in mammals, thereby addressing chronic inflammatory conditions such as rheumatoid arthritis and acute responses like those from injuries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used to address inflammatory responses, then the treatment approach is established, but the effectiveness in reducing chronic and acute inflammation is inadequate
Solution Approach 1:
The patent changes the molecular parameter by using apolipoprotein A2 and C3 polypeptides instead of conventional anti-inflammatory drugs. These apolipoproteins naturally regulate cytokine production and inflammatory responses, providing a more effective and targeted approach to reducing both acute and chronic inflammation without the harmful side effects of traditional treatments
Solution Approach 2:
The apolipoprotein A2 and C3 polypeptides act as intermediary substances that mediate the inflammatory response by binding to and regulating cytokines such as TNF, IL-6, and IL-8. This intermediary mechanism allows for precise control of inflammatory pathways, improving treatment effectiveness while reducing the harmful burden of chronic inflammation
Data Source
AI summary
The invention features methods of using serum factors such as Apolipoprotein A2 and Apolipoprotein C3 for reducing or preventing a chronic or acute inflammatory response (e.g., an inflammatory response due to an autoimmune disease or an injury).